The purpose of the this study is to evaluate the safety of efficacy of APC-111 775 mg MP tablet once daily dosing for 7 days for treating patients with strep throat. The evaluation will look to confirm if APC-111 eliminates the bacterial infection (Streptococcus pyogenes).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
500
Manford Gooch, MD
Salt Lake City, Utah, United States
Bacteriological outcome at the Test of Cure Visit
Bacteriological outcome at the Late Post Therapy Visit
Clinical Outcome
Safety
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.